RBC Wealth Management insights

There’s more to a long life than simply a long lifespan. The number of years we spend in good health, or healthspan, is key. With biotech spurring promising medical innovations, we look at how it can fit into investment portfolios.

The S&P 500 uptrend reached an all-time high, but there could be more challenges in Q3 and Q4. With market cap concentration, seasonality trends, and valuation concerns, is it time to rebalance your portfolio?

There are more positive than negative aspects of the Q2 S&P 500 earnings season. But there are some nuances within the Information Technology sector data that we think call for restraint.

As U.S. tariff policy continues to evolve, investors are facing more questions than answers. RBC Economics provides a roadmap on when and where tariffs will start to impact the U.S.

Running up debts to buy foreign goods is unsustainable in the long term. Identifying the problem is simple, but we see no easy or quick escape for the U.S. from the imbalances built up over the last four decades.

Markets are reacting to new tariffs and rising recession risks. Hyperion offers five advisor tested strategies to help investors stay focused, manage volatility, and protect their portfolios during uncertain times.

Stay informed with Market Week - Hyperion's weekly snapshot of what moved the markets and why it matters. From Fed updates to economic trends, we break it down in a digestible format.

RBC lowers S&P 500 target to 6,200 as GDP slows and inflation persist. Sentiment is bearish, but history suggests a rebound ahead. Small business and consumer confidence are weakening. What's next for investors?